Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Julie Rich Ingelfinger, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01DK058950 (INGELFINGER, JULIE R.) Sep 30, 2000 - Jul 31, 2005
    NIH/NIDDK
    PROXIMAL TUBULE ANGIOTENSINS--HEMOLYTIC UREMIC SYNDROME
    Role: Principal Investigator
  2. K08DK002048 (INGELFINGER, JULIE R.) Jun 1, 1993 - Jan 31, 2002
    NIH/NIDDK
    INTRACELLULAR PROCESSING OF RAT KIDNEY RENIN
    Role: Principal Investigator
  3. R01HL048455 (INGELFINGER, JULIE R.) May 1, 1992 - Mar 31, 2002
    NIH/NHLBI
    ROLES OF THE PROXIMAL TUBULE RENIN ANGIOTENSIN SYSTEM
    Role: Principal Investigator
  4. R01HL040210 (INGELFINGER, JULIE R.) Mar 1, 1988 - Feb 28, 1992
    NIH/NHLBI
    INTRARENAL ANGIOTENSINOGEN: LOCALIZATION ®ULATION
    Role: Principal Investigator
  5. F33HL006913 (INGELFINGER, JULIE R.) Feb 6, 1985
    NIH/NHLBI
    ONTOGENY OF RENIN IN PERINATAL LIFE
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Rosen CJ, Ingelfinger JR. Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention. N Engl J Med. 2019 Jun 09. PMID: 31180193.
    Citations:    
  2. Ghosh A, Zhao S, Lo CS, Maachi H, Chenier I, Lateef MA, Abdo S, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD. Heterogeneous Nuclear Ribonucleoprotein F Mediates Insulin Inhibition of Bcl2-Modifying Factor Expression and Tubulopathy in Diabetic Kidney. Sci Rep. 2019 Apr 30; 9(1):6687. PMID: 31040360.
    Citations:    
  3. Ingelfinger JR, Rosen CJ. Clinical Credence - SGLT2 Inhibitors, Diabetes, and Chronic Kidney Disease. N Engl J Med. 2019 06 13; 380(24):2371-2373. PMID: 30990261.
    Citations:    
  4. Hamdani G, Flynn JT, Daniels S, Falkner B, Hanevold C, Ingelfinger J, Lande MB, Martin LJ, Meyers KE, Mitsnefes M, Rosner B, Samuels J, Urbina EM. Ambulatory blood pressure monitoring tolerability and blood pressure status in adolescents: the SHIP AHOY study. Blood Press Monit. 2019 Feb; 24(1):12-17. PMID: 30451702.
    Citations:    Fields:    
  5. Ingelfinger JR. Tackling Tsc1 to Promote Nephrogenesis. N Engl J Med. 2018 12 20; 379(25):2476-2478. PMID: 30575479.
    Citations:    Fields:    Translation:Animals
  6. Hamdani G, Flynn JT, Becker RC, Daniels SR, Falkner B, Hanevold CD, Ingelfinger JR, Lande MB, Martin LJ, Meyers KE, Mitsnefes M, Rosner B, Samuels JA, Urbina EM. Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in Adolescents. Hypertension. 2018 10; 72(4):955-961. PMID: 30354718.
    Citations:    Fields:    
  7. Mendizábal B, Urbina EM, Becker R, Daniels SR, Falkner BE, Hamdani G, Hanevold CD, Hooper SR, Ingelfinger JR, Lande M, Martin LJ, Meyers K, Mitsnefes M, Rosner B, Samuels JA, Flynn JT. SHIP-AHOY (Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth). Hypertension. 2018 09; 72(3):625-631. PMID: 29987102.
    Citations:    Fields:    
  8. Ingelfinger JR, Rosen CJ. Lorcaserin - Elixir or Liability? N Engl J Med. 2018 09 20; 379(12):1174-1175. PMID: 30145932.
    Citations:    Fields:    Translation:Humans
  9. Rosen CJ, Ingelfinger JR. A Reliable Diagnostic Test for Hypotonic Polyuria. N Engl J Med. 2018 08 02; 379(5):483-484. PMID: 30067935.
    Citations:    Fields:    Translation:Humans
  10. Ingelfinger JR. A Remembrance of Life before Roe v. Wade. N Engl J Med. 2018 Aug 23; 379(8):708-709. PMID: 30020848.
    Citations:    Fields:    Translation:Humans
  11. Caulley L, Ramaswami R, Longo DL, Phimister EG, Ingelfinger JR, Ropper AH, Stern K, Burke AE, Knoper KM, Seals JJJ, Müller DC, Drazen JM. A Look Forward - The Frontiers in Medicine Series. N Engl J Med. 2018 07 05; 379(1):85-86. PMID: 29972760.
    Citations:    Fields:    
  12. Zhao XP, Chang SY, Liao MC, Lo CS, Chenier I, Luo H, Chiasson JL, Ingelfinger JR, Chan JSD, Zhang SL. Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes. Sci Rep. 2018 Apr 13; 8(1):5958. PMID: 29654303.
    Citations: 1     Fields:    
  13. Zhao S, Ghosh A, Lo CS, Chenier I, Scholey JW, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice. Endocrinology. 2018 02 01; 159(2):836-852. PMID: 29211853.
    Citations:    Fields:    Translation:AnimalsCells
  14. Ingelfinger JR. A Disturbing Legacy of Childhood Kidney Disease. N Engl J Med. 2018 02 01; 378(5):470-471. PMID: 29385363.
    Citations:    Fields:    Translation:Humans
  15. Kushak RI, Ozaki M, Rosales IA, Boyle DC, Colvin RB, Ingelfinger JR, Stahl GL, Grabowski EF. Both platelets and fibrin deposition are increased in the glomeruli of mice after treatment with Shiga toxin-2. Kidney Int. 2017 12; 92(6):1556-1557. PMID: 29153141.
    Citations:    Fields:    Translation:HumansAnimalsCells
  16. Ingelfinger JR. Tolvaptan and Autosomal Dominant Polycystic Kidney Disease. N Engl J Med. 2017 11 16; 377(20):1988-1989. PMID: 29105553.
    Citations: 1     Fields:    Translation:Humans
  17. Aymé S, Bockenhauer D, Day S, Devuyst O, Guay-Woodford LM, Ingelfinger JR, Klein JB, Knoers NVAM, Perrone RD, Roberts J, Schaefer F, Torres VE, Cheung M, Wheeler DC, Winkelmayer WC. Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 10; 92(4):796-808. PMID: 28938953.
    Citations:    Fields:    Translation:Humans
  18. Liao MC, Zhao XP, Chang SY, Lo CS, Chenier I, Takano T, Ingelfinger JR, Zhang SL. AT2 R deficiency mediated podocyte loss via activation of ectopic hedgehog interacting protein (Hhip) gene expression. J Pathol. 2017 11; 243(3):279-293. PMID: 28722118.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  19. Ingelfinger JR. A Bacterial IgG-Degrading Enzyme to Unhinge Antibodies. N Engl J Med. 2017 08 03; 377(5):487-489. PMID: 28767355.
    Citations:    Fields:    Translation:Humans
  20. Lo CS, Shi Y, Chenier I, Ghosh A, Wu CH, Cailhier JF, Ethier J, Lattouf JB, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD. Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice. Diabetes. 2017 07; 66(7):1964-1978. PMID: 28424160.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  21. Ingelfinger JR, Jarcho JA. Increase in the Incidence of Diabetes and Its Implications. N Engl J Med. 2017 04 13; 376(15):1473-1474. PMID: 28402766.
    Citations: 9     Fields:    Translation:Humans
  22. Ghosh A, Abdo S, Zhao S, Wu CH, Shi Y, Lo CS, Chenier I, Alquier T, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD. Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice. Endocrinology. 2017 04 01; 158(4):903-919. PMID: 28324005.
    Citations:    Fields:    Translation:AnimalsCells
  23. Ingelfinger JR. Acute Kidney Injury in Critically Ill Children - An Ominous Legacy. N Engl J Med. 2017 01 05; 376(1):82-83. PMID: 27959706.
    Citations:    Fields:    Translation:Humans
  24. Rosen CJ, Ingelfinger JR. Building Better Bones with Biologics - A New Approach to Osteoporosis? N Engl J Med. 2016 10 20; 375(16):1583-1584. PMID: 27641359.
    Citations: 1     Fields:    Translation:Humans
  25. Chang SY, Lo CS, Zhao XP, Liao MC, Chenier I, Bouley R, Ingelfinger JR, Chan JS, Zhang SL. Overexpression of angiotensinogen downregulates aquaporin 1 expression via modulation of Nrf2-HO-1 pathway in renal proximal tubular cells of transgenic mice. J Renin Angiotensin Aldosterone Syst. 2016 Jul; 17(3). PMID: 27638854.
    Citations:    Fields:    Translation:AnimalsCells
  26. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Reply to comment on World Kidney Day 2016: averting the legacy of kidney disease-focus on childhood. Pediatr Nephrol. 2016 10; 31(10):1711. PMID: 27363712.
    Citations:    Fields:    Translation:Humans
  27. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Erratum to "Averting the legacy of kidney disease-Focus on childhood" [Nephrol. Ther. 12 (1) (2016) 1-5]. Nephrol Ther. 2016 Jul; 12(4):257. PMID: 27316577.
    Citations:    Fields:    
  28. Ingelfinger JR, Rosen CJ. Cardiac and Renovascular Complications in Type 2 Diabetes--Is There Hope? N Engl J Med. 2016 Jul 28; 375(4):380-2. PMID: 27331286.
    Citations: 6     Fields:    Translation:Humans
  29. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease: focus on childhood. Curr Opin Organ Transplant. 2016 06; 21(3):343-8. PMID: 27077601.
    Citations:    Fields:    
  30. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Erratum to: Averting the legacy of kidney disease: focus on childhood. J Nephrol. 2016 Jun; 29(3):457. PMID: 27105882.
    Citations:    Fields:    
  31. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. [Erratum of "In time: averting the legacy of kidney disease - focus on childhood" [Rev Paul Pediatr. 2016;34(1):5-10]]. Rev Paul Pediatr. 2016 06; 34(2):247-248. PMID: 27197695.
    Citations:    Fields:    
  32. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the Legacy of Kidney Disease: Focus on Childhood. Int J Organ Transplant Med. 2016; 7(2):61-68. PMID: 28435637.
    Citations: 1     
  33. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease: focus on childhood. Curr Opin Nephrol Hypertens. 2016 May; 25(3):153-8. PMID: 26886456.
    Citations: 1     Fields:    Translation:Humans
  34. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease: focus on childhood. Nephrol Dial Transplant. 2016 06; 31(6):1023. PMID: 27190326.
    Citations:    Fields:    
  35. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease - focus on childhood. Braz J Med Biol Res. 2016; 49(5):e5314. PMID: 27096201.
    Citations:    Fields:    Translation:Humans
  36. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease: focus on childhood. Future Sci OA. 2016 Jun; 2(2):FSO112. PMID: 28031959.
    Citations:    
  37. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease - focus on childhood. Afr J Prim Health Care Fam Med. 2016 Apr 08; 8(1):e1-5. PMID: 27247150.
    Citations:    Fields:    Translation:Humans
  38. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease: focus on childhood. J Nephrol. 2016 Apr; 29(2):137-142. PMID: 26960419.
    Citations:    Fields:    Translation:Humans
  39. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the Legacy of Kidney Disease--Focus on Childhood. Am J Hypertens. 2016 Apr; 29(4):537-41. PMID: 26965180.
    Citations:    Fields:    Translation:Humans
  40. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. World Kidney Day 2016: Averting the legacy of kidney disease. Focus on childhood. Rev Chil Pediatr. 2016 Mar 10. PMID: 26972680.
    Citations:    Fields:    
  41. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. [World Kidney Day 2016: Averting the legacy of kidney disease. Focus on childhood]. Rev Chil Pediatr. 2016 Mar-Apr; 87(2):82-7. PMID: 26948456.
    Citations:    Fields:    Translation:Humans
  42. Ingelfinger JR, Schaefer F, Kalantar-Zadeh K. Averting the legacy of kidney disease-focus on childhood. J Bras Nefrol. 2016 Mar; 38(1):2-8. PMID: 27049358.
    Citations:    Fields:    Translation:Humans
  43. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease--focus on childhood. Kidney Int. 2016 Mar; 89(3):512-8. PMID: 26880442.
    Citations: 1     Fields:    Translation:Humans
  44. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the Legacy of Kidney Disease - Focus on Childhood. Blood Purif. 2016; 41(4):332-8. PMID: 26930219.
    Citations:    Fields:    Translation:Humans
  45. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. World Kidney Day 2016: Averting the Legacy of Kidney Disease--Focus on Childhood. Am J Kidney Dis. 2016 Mar; 67(3):349-54. PMID: 26916370.
    Citations: 1     Fields:    Translation:Humans
  46. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. World Kidney Day 2016 Averting The Legacy of Kidney Disease-Focus On Childhood. J Ren Care. 2016 Mar; 42(1):3-6. PMID: 26856392.
    Citations:    Fields:    Translation:Humans
  47. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease - focus on childhood. Physiol Int. 2016 Mar; 103(1):3-11. PMID: 27030623.
    Citations:    Fields:    Translation:Humans
  48. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease - Focus on childhood. Saudi J Kidney Dis Transpl. 2016 Mar; 27(2):219-26. PMID: 26997373.
    Citations:    Fields:    Translation:Humans
  49. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease: Focus on childhood. Indian J Nephrol. 2016 Mar-Apr; 26(2):71-6. PMID: 27051128.
    Citations: 1     
  50. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease: focus on childhood. Nephrol Dial Transplant. 2016 Mar; 31(3):327-31. PMID: 26908830.
    Citations: 1     Fields:    
  51. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the Legacy of Kidney Disease - Focus on Childhood. Nephron. 2016; 132(3):161-7. PMID: 26926120.
    Citations:    Fields:    Translation:Humans
  52. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the Legacy of Kidney Disease--Focus on Childhood. Am J Nephrol. 2016; 43(1):58-64. PMID: 26895161.
    Citations:    Fields:    Translation:Humans
  53. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. World Kidney Day 2016: averting the legacy of kidney disease-focus on childhood. Arch Argent Pediatr. 2016 Apr; 114(2):147-53. PMID: 27079393.
    Citations:    Fields:    Translation:Humans
  54. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the Legacy of Kidney Disease - Focus on Childhood. Kidney Dis (Basel). 2016 Apr; 2(1):46-52. PMID: 27536691.
    Citations:    
  55. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the Legacy of Kidney Disease-Focus on Childhood. Children (Basel). 2016 02 08; 3(1). PMID: 27417242.
    Citations:    
  56. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease: focus on childhood. Intern Med J. 2016 Feb; 46(2):133-8. PMID: 26899885.
    Citations:    Fields:    Translation:Humans
  57. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. World kidney day 2016 Averting the legacy of kidney disease--- focus on childhood. Clin Nephrol. 2016 Feb; 85(2):63-9. PMID: 26772048.
    Citations:    Fields:    Translation:HumansPHPublic Health
  58. Lurbe E, Ingelfinger JR. Blood pressure in children and adolescents: current insights. J Hypertens. 2016 Feb; 34(2):176-83. PMID: 26599224.
    Citations: 3     Fields:    Translation:Humans
  59. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. World Kidney Day 2016: Averting the legacy of kidney disease-focus on childhood. Pediatr Nephrol. 2016 Mar; 31(3):343-8. PMID: 26884120.
    Citations: 4     Fields:    Translation:Humans
  60. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F, Kam Tao Li P, Garcia-Garcia G, Couser WG, Erk T, Ingelfinger JR, Kalantar-Zadeh K, Kernahan C, Osafo C, Riella MC, Segantini L, Zakharova E. Averting the legacy of kidney disease-Focus on childhood. Nephrol Ther. 2016 Feb; 12(1):1-5. PMID: 26822334.
    Citations:    Fields:    Translation:Humans
  61. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. [In time: averting the legacy of kidney disease - focus on childhood]. Rev Paul Pediatr. 2016 Jan-Mar; 34(1):5-10. PMID: 26846738.
    Citations:    Fields:    Translation:Humans
  62. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Editorial: World Kidney Day 2016: Averting the Legacy of Kidney Disease--Focus on Childhood. Semin Nephrol. 2016 Jan; 36(1):1-6. PMID: 27085729.
    Citations:    Fields:    Translation:Humans
  63. Ingelfinger JR, Rosen CJ. Cardiovascular Risk and Sodium-Glucose Cotransporter 2 Inhibition in Type 2 Diabetes. N Engl J Med. 2015 Nov 26; 373(22):2178-9. PMID: 26605932.
    Citations: 3     Fields:    Translation:Humans
  64. Aliou Y, Liao MC, Zhao XP, Chang SY, Chenier I, Ingelfinger JR, Zhang SL. Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes. Pediatr Res. 2016 Mar; 79(3):416-24. PMID: 26571223.
    Citations: 5     Fields:    Translation:Animals
  65. Rosen CJ, Ingelfinger JR. Unraveling the Function of FTO Variants. N Engl J Med. 2015 Sep 03; 373(10):964-5. PMID: 26287747.
    Citations:    Fields:    Translation:HumansAnimalsCells
  66. Lo CS, Shi Y, Chang SY, Abdo S, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-ß1-induced kidney injury in a mouse model of diabetes. Diabetologia. 2015 Oct; 58(10):2443-54. PMID: 26232095.
    Citations: 4     Fields:    Translation:Animals
  67. Shi Y, Lo CS, Padda R, Abdo S, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clin Sci (Lond). 2015 May 01; 128(10):649-63. PMID: 25495544.
    Citations: 20     Fields:    Translation:Animals
  68. Grabowski EF, Liu B, Gerace MR, Kushak RI, Ingelfinger JR. Shiga toxin-1 Decreases Endothelial Cell Tissue Factor Pathway Inhibitor Not Co-localized with Tissue Factor on the Cell Membrane. Thromb Res. 2015 Jun; 135(6):1214-7. PMID: 25864889.
    Citations:    Fields:    Translation:HumansAnimalsCells
  69. Ingelfinger JR, Rubin EJ. The HIV-positive transplant donor--change born of necessity. N Engl J Med. 2015 Feb 12; 372(7):663-5. PMID: 25671260.
    Citations: 1     Fields:    Translation:Humans
  70. Ingelfinger JR. A new era for the treatment of hyperkalemia? N Engl J Med. 2015 Jan 15; 372(3):275-7. PMID: 25415806.
    Citations: 6     Fields:    Translation:Humans
  71. Ellison DH, Ingelfinger JR. A quest--halting the progression of autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec 11; 371(24):2329-31. PMID: 25399732.
    Citations: 5     Fields:    Translation:Humans
  72. Ingelfinger JR. The child or adolescent with elevated blood pressure. N Engl J Med. 2014 09 11; 371(11):1075. PMID: 25207779.
    Citations:    Fields:    Translation:Humans
  73. Zhao XP, Liao MC, Chang SY, Abdo S, Aliou Y, Chenier I, Ingelfinger JR, Zhang SL. Maternal diabetes modulates kidney formation in murine progeny: the role of hedgehog interacting protein (HHIP). Diabetologia. 2014 Sep; 57(9):1986-96. PMID: 24957663.
    Citations: 2     Fields:    Translation:Animals
  74. Ingelfinger JR. Clinical practice. The child or adolescent with elevated blood pressure. N Engl J Med. 2014 Jun 12; 370(24):2316-25. PMID: 24918374.
    Citations: 13     Fields:    Translation:Humans
  75. Abdo S, Shi Y, Otoukesh A, Ghosh A, Lo CS, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice. Diabetes. 2014 Oct; 63(10):3483-96. PMID: 24812425.
    Citations: 13     Fields:    Translation:AnimalsCells
  76. Ingelfinger JR, Stapleton FB. Antibiotic prophylaxis for vesicoureteral reflux--answers, yet questions. N Engl J Med. 2014 Jun 19; 370(25):2440-1. PMID: 24795143.
    Citations: 1     Fields:    Translation:Humans
  77. Chan JS, Abdo S, Ghosh A, Alquier T, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Ross EA, Willenberg BJ, Oca-Cossio J, Clapp WL, Terada N, Abrahamson DR, Ellison GW, Matthews CE, Batich CD, Ihoriya C, Satoh M, Sasaki T, Kashihara N, Piwkowska A, Rogacka D, Angielski S, Jankowski M, Pontrelli P, Conserva F, Papale M, Accetturo M, Gigante M, Vocino G, Dipalma AM, Grandaliano G, Di Paolo S, Gesualdo L, Franzén S, Pihl L, Khan N, Gustafsson H, Palm F, Koszegi S, Hodrea J, Lenart L, Hosszu A, Wagner L, Vannay A, Tulassay T, Szabo A, Fekete A, Aoki R, Sekine F, Kikuchi K, Miyazaki S, Yamashita Y, Itoh Y, Kölling M, Park JK, Haller H, Thum T, Lorenzen J, Hirayama A, Yoh K, Ueda A, Itoh H, Owada S, Kokeny G, Szabó L, Fazekas K, Rosivall L, Mózes MM, Kim Y, Koh ES, Lim JH, Kim MY, Chang YS, Park CW, Kim Y, Kim HW, Kim MY, Lim JH, Chang YS, Park CW, Shin BC, Kim HL, Chung JH, Chan JS, Wu TC, Chen JW, Rogacka D, Piwkowska A, Angielski S, Jankowski M, Clotet S, Soler MJ, Rebull M, Pascual J, Riera M, Patinha D, Afonso J, Sousa T, Morato M, Albino-Teixeira A, Kim H, Min HS, Kang MJ, Kim JE, Lee JE, Kang YS, Cha DR, Jo YI, Seo EH, Kim JD, Lee SH, Jorge L, Silva KA, Luiz RS, Rampaso RR, Lima W, Cunha TS, Schor N, Lee HJ, Park JY, Kim SK, Moon JY, Lee SH, Ihm CG, Lee TW, Jeong KH, Moon JY, Kim S, Park JY, Kim SY, Kim YG, Jeong KH, Lee SH, Ihm CG, Marques C, Mega C, Gonçalves A, Rodrigues-Santos P, Teixeira-Lemos E, Teixeira F, Fontes Ribeiro C, Reis F, Fernandes R, Sutariya BK, Badgujar LB, Kshtriya AA, Saraf MN, Chiu CH, Lee WC, Chau YY, Lee LC, Lee CT, Chen JB, Dahan I, Nakhoul F, Thawho N, Ben-Itzhaq O, Levy AP, Conserva F, Pontrelli P, Accetturo M, Cordisco G, Fiorentino L, Federici M, Grandaliano G, Di Paolo S, Gesualdo L, Wystrychowski G, Havel PJ, Graham JL, Zukowska-Szczechowska E, Obuchowicz E, Psurek A, Grzeszczak W, Wystrychowski A, Clotet S, Soler MJ, Rebull M, Gimeno J, Pascual J, Riera M, Almeida BZ, Seraphim DC, Punaro G, Nascimento M, Mouro M, Lanzoni VP, Lopes GS, Higa EM, Roca-Ho H, Riera M, Márquez E, Pascual J, Soler MJ. Diabetes experimental. Nephrol Dial Transplant. 2014 May; 29 Suppl 3:iii168-iii177. PMID: 24849955.
    Citations:    
  78. Ingelfinger JR. A remembrance of Mary ellen avery, m.d. Front Pediatr. 2014; 2:19. PMID: 24795869.
    Citations:    
  79. Falkner B, Ingelfinger J. Understanding the power of perinatal events and metabolic status in childhood. Hypertension. 2014 Jun; 63(6):1166-7. PMID: 24688124.
    Citations:    Fields:    Translation:Humans
  80. Ingelfinger JR. Past mortality risk and survival: living well and growing up. Am J Kidney Dis. 2013 Nov; 62(5):880-2. PMID: 24157272.
    Citations:    Fields:    
  81. Ingelfinger JR, Marsden PA. Estimated GFR and risk of death--is cystatin C useful? N Engl J Med. 2013 Sep 05; 369(10):974-5. PMID: 24004125.
    Citations: 3     Fields:    Translation:Humans
  82. Ingelfinger JR, Alexander SI. One step closer to "Rejectostix". N Engl J Med. 2013 Jul 04; 369(1):84-5. PMID: 23822781.
    Citations:    
  83. Grabowski EF, Kushak RI, Liu B, Ingelfinger JR. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium. Thromb Res. 2013 Jun; 131(6):521-8. PMID: 23642803.
    Citations: 2     Fields:    Translation:HumansCells
  84. Abdo S, Lo CS, Chenier I, Shamsuyarova A, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice. Diabetologia. 2013 Jul; 56(7):1649-60. PMID: 23609310.
    Citations: 6     Fields:    Translation:Animals
  85. Shi Y, Lo CS, Chenier I, Maachi H, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice. Am J Physiol Renal Physiol. 2013 Jun 01; 304(11):F1335-46. PMID: 23552863.
    Citations: 11     Fields:    Translation:Animals
  86. Chang SY, Chen YW, Zhao XP, Chenier I, Tran S, Sauvé A, Ingelfinger JR, Zhang SL. Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system. Diabetes. 2012 Oct; 61(10):2565-74. PMID: 22733796.
    Citations: 15     Fields:    Translation:Animals
  87. Lo CS, Chang SY, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes. 2012 Oct; 61(10):2597-608. PMID: 22664958.
    Citations: 12     Fields:    Translation:Animals
  88. Ingelfinger JR. Selective, isolated proximal tubular angiotensinogen overexpression and salt-sensitive hypertension. Am J Hypertens. 2012 Jun; 25(6):628. PMID: 22592314.
    Citations: 1     Fields:    Translation:Animals
  89. Ingelfinger JR, Nuyt AM. Impact of fetal programming, birth weight, and infant feeding on later hypertension. J Clin Hypertens (Greenwich). 2012 Jun; 14(6):365-71. PMID: 22672090.
    Citations: 11     Fields:    Translation:Humans
  90. Satou R, Miyata K, Gonzalez-Villalobos RA, Ingelfinger JR, Navar LG, Kobori H. Interferon-? biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J. 2012 May; 26(5):1821-30. PMID: 22302831.
    Citations: 27     Fields:    Translation:AnimalsCells
  91. Lau GJ, Godin N, Maachi H, Lo CS, Wu SJ, Zhu JX, Brezniceanu ML, Chénier I, Fragasso-Marquis J, Lattouf JB, Ethier J, Filep JG, Ingelfinger JR, Nair V, Kretzler M, Cohen CD, Zhang SL, Chan JS. Bcl-2-modifying factor induces renal proximal tubular cell apoptosis in diabetic mice. Diabetes. 2012 Feb; 61(2):474-84. PMID: 22210314.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  92. Lo CS, Liu F, Shi Y, Maachi H, Chenier I, Godin N, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Am J Physiol Renal Physiol. 2012 Apr 01; 302(7):F840-52. PMID: 22205225.
    Citations: 21     Fields:    Translation:Animals
  93. Ingelfinger JR. Bariatric surgery in adolescents. N Engl J Med. 2011 Oct 13; 365(15):1365-7. PMID: 21995381.
    Citations: 12     Fields:    Translation:Humans
  94. Lamas DJ, Ingelfinger JR, Rosenbaum LS. Clinical decisions. Treatment of a 6-year-old girl with vesicoureteral reflux--polling results. N Engl J Med. 2011 Aug 25; 365(8):e17. PMID: 21864164.
    Citations:    Fields:    Translation:Humans
  95. Ingelfinger JR. MYO1E, focal segmental glomerulosclerosis, and the cytoskeleton. N Engl J Med. 2011 Jul 28; 365(4):368-9. PMID: 21751899.
    Citations: 5     Fields:    Translation:HumansCells
  96. Ingelfinger JR, Drazen JM. Patient organizations and research on rare diseases. N Engl J Med. 2011 Apr 28; 364(17):1670-1. PMID: 21410388.
    Citations: 8     Fields:    Translation:Humans
  97. Ingelfinger JR. Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes. N Engl J Med. 2011 Mar 10; 364(10):970-1. PMID: 21388316.
    Citations: 8     Fields:    Translation:Humans
  98. Chen YW, Chenier I, Chang SY, Tran S, Ingelfinger JR, Zhang SL. High glucose promotes nascent nephron apoptosis via NF-kappaB and p53 pathways. Am J Physiol Renal Physiol. 2011 Jan; 300(1):F147-56. PMID: 20962117.
    Citations: 10     Fields:    Translation:AnimalsCells
  99. Ingelfinger JR. Hypertension control in African-American patients with chronic kidney disease. N Engl J Med. 2010 Sep 02; 363(10):974-6. PMID: 20818909.
    Citations:    Fields:    Translation:Humans
  100. Hoy WE, Ingelfinger JR, Hallan S, Hughson MD, Mott SA, Bertram JF. The early development of the kidney and implications for future health. J Dev Orig Health Dis. 2010 Aug; 1(4):216-33. PMID: 25141870.
    Citations: 21     Fields:    
  101. Daouk GH, Ingelfinger JR. Recent advances in the pathogenesis of hypertension in children. J Med Liban. 2010 Jul-Sep; 58(3):137-41. PMID: 21462841.
    Citations:    Fields:    Translation:Humans
  102. Brezniceanu ML, Lau CJ, Godin N, Chénier I, Duclos A, Ethier J, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J Am Soc Nephrol. 2010 Jun; 21(6):943-54. PMID: 20299359.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  103. Godin N, Liu F, Lau GJ, Brezniceanu ML, Chénier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int. 2010 Jun; 77(12):1086-97. PMID: 20237455.
    Citations: 31     Fields:    Translation:Animals
  104. Ingelfinger JR. Blood-pressure control and delay in progression of kidney disease in children. N Engl J Med. 2009 Oct 22; 361(17):1701-3. PMID: 19846857.
    Citations: 4     Fields:    Translation:Humans
  105. Bouley R, Palomino Z, Tang SS, Nunes P, Kobori H, Lu HA, Shum WW, Sabolic I, Brown D, Ingelfinger JR, Jung FF. Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression. Am J Physiol Renal Physiol. 2009 Dec; 297(6):F1575-86. PMID: 19776169.
    Citations: 10     Fields:    Translation:AnimalsCells
  106. Dötsch J, Plank C, Amann K, Ingelfinger J. The implications of fetal programming of glomerular number and renal function. J Mol Med (Berl). 2009 Sep; 87(9):841-8. PMID: 19652918.
    Citations: 13     Fields:    Translation:Humans
  107. Abitbol CL, Ingelfinger JR. Nephron mass and cardiovascular and renal disease risks. Semin Nephrol. 2009 Jul; 29(4):445-54. PMID: 19615565.
    Citations: 14     Fields:    T